171 related articles for article (PubMed ID: 24834983)
1. Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis.
Zhang H; Qi F; Cao Y; Chen M; Zu X
Med Sci Monit; 2014 May; 20():812-7. PubMed ID: 24834983
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
Zhang Y; Zhang Z; Li Z; Gong D; Zhan B; Man X; Kong C
Oncol Rep; 2016 Sep; 36(3):1293-300. PubMed ID: 27430325
[TBL] [Abstract][Full Text] [Related]
3. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features.
Li Y; Chen M; Yuan J; Zhou X; He W; Zu X; Qi L
Urol Int; 2014; 92(2):157-63. PubMed ID: 23988662
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
Majid S; Dar AA; Saini S; Deng G; Chang I; Greene K; Tanaka Y; Dahiya R; Yamamura S
PLoS One; 2013; 8(7):e67686. PubMed ID: 23844063
[TBL] [Abstract][Full Text] [Related]
7. Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.
Tian D; Hu H; Sun Y; Tang Y; Lei M; Liu L; Han R; Wu C
Mol Med Rep; 2015 Sep; 12(3):4522-4529. PubMed ID: 26129954
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of microRNA-100 in patients with bladder cancer.
Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
Ma L; Xu Z; Xu C; Jiang X
Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
[TBL] [Abstract][Full Text] [Related]
13. [Differential expression of hyaluronic acid synthase family in human bladder transitional cell carcinoma and its clinical significance].
Cai JL; Li M; Na YQ
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):121-5. PubMed ID: 21575480
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
[TBL] [Abstract][Full Text] [Related]
15. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
16. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
17. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma.
Xu K; Hou S; Du Z
Chin Med J (Engl); 2002 May; 115(5):743-5. PubMed ID: 12133547
[TBL] [Abstract][Full Text] [Related]
20. [DAB2IP expression in bladder transitional cell carcinoma and its correlation with clinical outcome].
Zhu JN; Wu KJ; Guan ZF; Liu LX; Ning ZY; Zhou JC; Wang XY; Fan JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):591-4. PubMed ID: 25286682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
